J. Michael Bishop, a distinguished American immunologist and microbiologist whose groundbreaking research into the genetic origins of cancer earned him a Nobel Prize, passed away on March 20, 2026, in San Francisco, California, at the age of 90. His son, Eliot, confirmed that the cause of death was pneumonia. Bishop's pioneering work fundamentally reshaped the understanding of cancer, moving it from a disease primarily viewed through external factors to one rooted in the malfunction of normal cellular genes. Major obituaries published by The Washington Post, the University of California, San Francisco (UCSF), and leading oncology publications have cemented his legacy as the scientist who ushered in the modern age of cancer biology.

Born John Michael Bishop on February 22, 1936, in York, Pennsylvania, his early life in a rural setting gave little indication of the profound scientific path he would forge. He began his education in a two-room schoolhouse before pursuing undergraduate studies at Gettysburg College, where he majored in chemistry. Bishop later earned his medical degree from Harvard Medical School in 1962. Following his medical training, he completed an internship and residency at Massachusetts General Hospital, where his interest in basic science began to solidify, leading to virology studies at the National Institutes of Health.

In 1968, Bishop accepted a faculty position at UCSF, a move that offered significantly greater opportunities for his burgeoning research ambitions. A pivotal collaboration began in 1970 when Harold E. Varmus joined Bishop's laboratory as a postdoctoral fellow. Together, they investigated the Rous sarcoma virus, known to cause cancer in chickens, and found that a gene similar to the virus's cancer-causing gene was also present in healthy cells. This revolutionary finding, published in 1976, demonstrated that oncogenes were not solely viral invaders but originated from normal cellular genes, which they termed proto-oncogenes. Their work revealed that these essential genes could be converted into cancer-causing oncogenes through genetic damage, laying the foundation for understanding the molecular mechanisms of cancer.

In recognition of their profound contributions to medicine, Bishop and Varmus were jointly awarded the Nobel Prize in Physiology or Medicine in 1989 for their discovery of the cellular origin of retroviral oncogenes. This revelation transformed cancer research and opened new avenues for targeted diagnosis and treatment. Bishop's illustrious career was marked by numerous other prestigious accolades, including the 1982 Albert Lasker Basic Medical Research Award and the National Medal of Science, which he received in 2003. He also shared his intellectual journey and insights into modern research in his 2003 memoir, "How to Win the Nobel Prize: An Unexpected Life in Science."

Beyond his laboratory breakthroughs, Dr. Bishop was a dedicated leader in academia who shaped the future of biomedical research institutions. He served as the director of the G.W. Hooper Research Foundation at UCSF, fostering an environment of rigorous scientific inquiry. From 1998 to 2009, he served as the eighth Chancellor of UCSF, presiding over a period of significant expansion that included the development of the UCSF Mission Bay campus. His tenure as chancellor was the longest in the institution's history, marked by a steadfast commitment to advancing biomedical science and education.

Bishop was equally revered for his dedication to the next generation of scientists. Former postdoctoral fellow Deborah Spector publicly praised Bishop and Varmus for their supportive mentorship, noting their deep respect for trainees' work and collaborative spirit. UCSF Chancellor Sam Hawgood released a statement honoring his predecessor, calling Bishop a "titan of science and a pillar of the UCSF community." Hawgood emphasized that Bishop's research "forever changed our understanding of cancer," highlighting his transformative impact on both the university and the wider scientific world.

Dr. Bishop's personal life was anchored by his deep devotion to his family and his broad intellectual interests. He was predeceased by his wife, Kathryn, who passed away in 2016. He is survived by his two sons, Dylan and Eliot, a sister, and five grandchildren. J. Michael Bishop's legacy is one of transformative scientific inquiry and unwavering dedication to combating humanity's most feared disease. His foundational discoveries continue to inspire generations of scientists and clinicians, leaving an indelible mark on the lives of countless individuals affected by cancer.